sideBackJeremy has over 20 years experience in the medical sciences field. Since August 2000, he founded and has served as executive chairman of BioScience Managers Limited, a corporate and investment advisory firm. From 1987 to 2000 he was a Director of Rothschild Asset Management Ltd, responsible for the Rothschild Bioscience Unit. He was invited to join Rothschilds by the Chairman of Biotechnology Investments Limited, Lord (Victor) Rothschild.

The creation of the Rothschild Bioscience Unit fuelled the development of additional funds, including the Australian Bioscience Trust (Australia’s first fund dedicated to investments in biotechnology), and the International Biotechnology Trust (IBT), a London Stock Exchange listed investment trust focused on mid-staged companies active in the field of human healthcare. Jeremy retired from Rothschilds at the end of July 2000, and subsequently the management of IBT was transferred to Schroder Ventures Limited (now SV Life Science Managers Ltd).

Jeremy founded BioScience Managers in 2000 which has now been acquired by Excalibur. He holds a MA in Natural Sciences from Trinity College, Dublin. Jeremy is a director of the Excalibur board with particular emphasis on international venture capital fund management.